CA2131101A1 - Compositions ophtalmiques topiques qui renferment une combinaison d'antagonistes du calcium comprenant des agents reconnus efficaces contre le glaucome - Google Patents

Compositions ophtalmiques topiques qui renferment une combinaison d'antagonistes du calcium comprenant des agents reconnus efficaces contre le glaucome

Info

Publication number
CA2131101A1
CA2131101A1 CA002131101A CA2131101A CA2131101A1 CA 2131101 A1 CA2131101 A1 CA 2131101A1 CA 002131101 A CA002131101 A CA 002131101A CA 2131101 A CA2131101 A CA 2131101A CA 2131101 A1 CA2131101 A1 CA 2131101A1
Authority
CA
Canada
Prior art keywords
composition
compound
intraocular pressure
lowers
calcium antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002131101A
Other languages
English (en)
Inventor
Louis Desantis Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2131101A1 publication Critical patent/CA2131101A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002131101A 1992-05-13 1993-05-12 Compositions ophtalmiques topiques qui renferment une combinaison d'antagonistes du calcium comprenant des agents reconnus efficaces contre le glaucome Abandoned CA2131101A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88232892A 1992-05-13 1992-05-13
US882,328 1992-05-13

Publications (1)

Publication Number Publication Date
CA2131101A1 true CA2131101A1 (fr) 1993-11-25

Family

ID=25380354

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002131101A Abandoned CA2131101A1 (fr) 1992-05-13 1993-05-12 Compositions ophtalmiques topiques qui renferment une combinaison d'antagonistes du calcium comprenant des agents reconnus efficaces contre le glaucome

Country Status (5)

Country Link
EP (1) EP0639986A1 (fr)
JP (1) JPH07508030A (fr)
AU (1) AU4246793A (fr)
CA (1) CA2131101A1 (fr)
WO (1) WO1993023082A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686879B1 (fr) * 1992-02-05 1994-03-18 Adir Cie Nouveaux composes de 1,4-dihydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5756502A (en) * 1994-08-08 1998-05-26 Warner-Lambert Company Quinazolinone derivatives as cholyecystokinin (CCK) ligands
DE4430128A1 (de) * 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
US5733938A (en) * 1994-09-09 1998-03-31 Allergan Combination of levobunolol and dipivefrin for topical ophthalmic use
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
ATE289815T1 (de) 1995-12-21 2005-03-15 Alcon Lab Inc Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
JP3541389B2 (ja) 1996-04-26 2004-07-07 藤沢薬品工業株式会社 ジヒドロピリジン化合物を含有する眼組織末梢循環改善剤
WO1997045118A1 (fr) * 1996-05-27 1997-12-04 Otsuka Pharmaceutical Co., Ltd. Agents ameliorant le flux sanguin ophtalmovasculaire et agents protecteurs des papilles optiques
DE69739190D1 (de) * 1996-10-28 2009-02-12 Senju Pharma Co Arzneimittel zur behandlung von oculären kreislauferkrankungen
IT1295423B1 (it) * 1997-10-10 1999-05-12 Medivis S R L Uso della flunarizina nella terapia topica del glaucoma
ES2224597T3 (es) 1998-01-29 2005-03-01 Akzo Nobel N.V. Agentes que mejoran la circulacion optica papilar.
AU3328600A (en) * 1999-03-25 2000-10-16 Santen Pharmaceutical Co. Ltd. Ocular tension-lowering agents
US6482854B1 (en) 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
DE60014629T2 (de) * 1999-04-14 2006-02-23 Senju Pharmaceutical Co., Ltd. 1,4-dihydropyridinderivate als Inhibitoren einer Sehunterfunktion, hervorgerufen durch eine Sehnervzellenverletzung, die durch andere Faktoren als optischen Durchblutungstörungen induziert wird.
US6462066B2 (en) 1999-12-02 2002-10-08 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
ATE266666T1 (de) * 2000-03-23 2004-05-15 Ortho Mcneil Pharm Inc Thiepino(3,2-b)dihydropyridine und relatierte zusammensetzungen und verfahren
US6562824B2 (en) * 2000-05-30 2003-05-13 Ortho-Mcneil Pharmaceutical, Inc. Dihydropyridine soft drugs, and related compositions and methods
US20040242565A1 (en) * 2001-09-11 2004-12-02 Yoshinori Toshima Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
TW200306839A (en) 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
JPWO2003082234A1 (ja) * 2002-03-28 2005-07-28 株式会社資生堂 フェニルアセトニトリル誘導体及びこれを含有する養毛剤、皮膚外用剤
EP1568382B1 (fr) 2002-11-18 2013-11-06 Santen Pharmaceutical Co., Ltd. Medicament contre le glaucome comprenant un inhibiteur de la rho-kinase et un betabloquant
WO2004069275A1 (fr) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation Medicaments ophtalmiques
JP5576659B2 (ja) * 2006-12-05 2014-08-20 ザ ロイヤル インスティテューション フォー ジ アドバンスメント オブ ラーニング／ マギル ユニバーシティ Ｔｒｋレセプター調節因子の使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2577802B1 (fr) * 1985-02-26 1987-07-24 Synthelabo Compositions pharmaceutiques a base de betaxolol et de nifedipine
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
FR2593395A1 (fr) * 1986-01-28 1987-07-31 Corbiere Jerome Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
CA2064160C (fr) * 1991-03-27 1998-08-11 Paul J. T. Missel Emploi de polysaccharides gelifiants combines a des substrats finement divises a action de vecteur des medicaments, dans des compositions ophthalmiques a usage local

Also Published As

Publication number Publication date
WO1993023082A1 (fr) 1993-11-25
AU4246793A (en) 1993-12-13
JPH07508030A (ja) 1995-09-07
EP0639986A1 (fr) 1995-03-01

Similar Documents

Publication Publication Date Title
CA2131101A1 (fr) Compositions ophtalmiques topiques qui renferment une combinaison d'antagonistes du calcium comprenant des agents reconnus efficaces contre le glaucome
AU720326B2 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
DE69733611T2 (de) Verfahren und potenzierte zusammensetzung zur behandlung von migräne
JP4934653B2 (ja) Ｒｈｏキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
JP2009298808A (ja) Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
JPH10503470A (ja) 減少した粘度を有する眼科治療用組成物
JP2002527392A (ja) 末梢的に作用する抗掻痒アヘン剤
KR20010021865A (ko) 카파 작용제 항소양성 약학적 조성물 및 이를 이용한소양증의 치료 방법
JP4482726B2 (ja) Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
AU704938B2 (en) Combination therapy for treating glaucoma
KR20010021854A (ko) 말초 작용성 항소양성 아편제
McLAUGHLIN et al. A synopsis of recent developments in antiglaucoma drugs
AU2001278708A1 (en) Adenosine derivatives and use thereof
CA2164733A1 (fr) Methodes et compositions pour abaisser la pression intraoculaire
WO2019131901A1 (fr) Préparation pharmaceutique contenant un composé d'acide pyridylaminoacétique
US4617306A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
CA2240271C (fr) Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires
KR20200103042A (ko) 세페타프로스트와 Rho 키나아제 저해제의 조합 의약
WO1998014193A1 (fr) Utilisation d'un antagoniste de la substance p dans la fabrication d'un medicament pour traiter les douleurs oculaires
CA2324116A1 (fr) Antagonistes du recepteur nk-1 et eletriptan pour le traitement de la migraine
MXPA99011155A (en) Peripherally acting anti-pruritic opiates

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead